Related Articles for PubMed (Select 18492281)

VEGF receptor antagonist Cyclo-VEGI reduces inflammatory reactivity and vascular leakiness and is neuroprotective against acute excitotoxic striatal insult.

Ryu JK, McLarnon JG.

J Neuroinflammation. 2008 May 20;5:18.

PMID: 18492281 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Depletion of neutrophils reduces neuronal degeneration and inflammatory responses induced by quinolinic acid in vivo.

Ryu JK, Tran KC, McLarnon JG.

Glia. 2007 Mar;55(4):439-51.

PMID: 17203474 [PubMed - indexed for MEDLINE]

Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum.

Ryu JK, Choi HB, McLarnon JG.

Neurobiol Dis. 2005 Nov;20(2):550-61.

PMID: 15916899 [PubMed - indexed for MEDLINE]

Design, synthesis, and evaluation of original carriers for targeting vascular endothelial growth factor receptor interactions.

Gonçalves M, Estieu-Gionnet K, Berthelot T, Laïn G, Bayle M, Canron X, Betz N, Bikfalvi A, Déléris G.

Pharm Res. 2005 Aug;22(8):1411-21. Epub 2005 Aug 3.

PMID: 16078152 [PubMed - indexed for MEDLINE]

Protective role of melatonin in domoic acid-induced neuronal damage in the hippocampus of adult rats.

Ananth C, Gopalakrishnakone P, Kaur C.

Hippocampus. 2003;13(3):375-87.

PMID: 12722978 [PubMed - indexed for MEDLINE]

Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease.

Ryu JK, Choi HB, McLarnon JG.

Neuroscience. 2006 Sep 15;141(4):1835-48. Epub 2006 Jun 30.

PMID: 16809003 [PubMed - indexed for MEDLINE]

Inhibition of integrin alphavbeta3 ameliorates focal cerebral ischemic damage in the rat middle cerebral artery occlusion model.

Shimamura N, Matchett G, Yatsushige H, Calvert JW, Ohkuma H, Zhang J.

Stroke. 2006 Jul;37(7):1902-9. Epub 2006 Jun 1.

PMID: 16741177 [PubMed - indexed for MEDLINE]

A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.

Massieu L, Thedinga KH, McVey M, Fagg GE.

Neuroscience. 1993 Aug;55(4):883-92.

PMID: 7694181 [PubMed - indexed for MEDLINE]

The 1993 Upjohn Award Lecture. Quinolinic acid induced brain neurotransmitter deficits: modulation by endogenous excitotoxin antagonists.

Jhamandas KH, Boegman RJ, Beninger RJ.

Can J Physiol Pharmacol. 1994 Dec;72(12):1473-82. Review.

PMID: 7736338 [PubMed - indexed for MEDLINE]

10:

Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease.

Araujo DM, Hilt DC.

Neuroscience. 1997 Dec;81(4):1099-110.

PMID: 9330371 [PubMed - indexed for MEDLINE]

11:

A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain.

Ryu JK, McLarnon JG.

J Cell Mol Med. 2008 Jul 24. [Epub ahead of print]

PMID: 18657226 [PubMed - as supplied by publisher]

12:

Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types.

Figueredo-Cardenas G, Harris CL, Anderson KD, Reiner A.

Exp Neurol. 1998 Feb;149(2):356-72.

PMID: 9500958 [PubMed - indexed for MEDLINE]

13:

Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease.

Senatorov VV, Ren M, Kanai H, Wei H, Chuang DM.

Mol Psychiatry. 2004 Apr;9(4):371-85.

PMID: 14702090 [PubMed - indexed for MEDLINE]

14:

Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum.

Popoli P, Pintor A, Domenici MR, Frank C, Tebano MT, Pèzzola A, Scarchilli L, Quarta D, Reggio R, Malchiodi-Albedi F, Falchi M, Massotti M.

J Neurosci. 2002 Mar 1;22(5):1967-75.

PMID: 11880527 [PubMed - indexed for MEDLINE]

15:

Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor.

Zilberberg L, Shinkaruk S, Lequin O, Rousseau B, Hagedorn M, Costa F, Caronzolo D, Balke M, Canron X, Convert O, Laïn G, Gionnet K, Goncalvès M, Bayle M, Bello L, Chassaing G, Deleris G, Bikfalvi A.

J Biol Chem. 2003 Sep 12;278(37):35564-73. Epub 2003 Jul 1.

PMID: 12837752 [PubMed - indexed for MEDLINE]

16:

Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats.

Figueredo-Cardenas G, Anderson KD, Chen Q, Veenman CL, Reiner A.

Exp Neurol. 1994 Sep;129(1):37-56.

PMID: 7925841 [PubMed - indexed for MEDLINE]

17:

Antioxidant treatment protects striatal neurons against excitotoxic insults.

Nakao N, Grasbon-Frodl EM, Widner H, Brundin P.

Neuroscience. 1996 Jul;73(1):185-200.

PMID: 8783241 [PubMed - indexed for MEDLINE]

18:

Excitotoxic injury stimulates pro-drug-induced 7-chlorokynurenate formation in the rat striatum in vivo.

Lee SC, Schwarcz R.

Neurosci Lett. 2001 May 25;304(3):185-8.

PMID: 11343833 [PubMed - indexed for MEDLINE]

19:

Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid.

Miranda AF, Boegman RJ, Beninger RJ, Jhamandas K.

Neuroscience. 1997 Jun;78(4):967-75.

PMID: 9174065 [PubMed - indexed for MEDLINE]

20:

NGF reduces striatal excitotoxic neuronal loss without affecting concurrent neuronal stress.

Frim DM, Yee WM, Isacson O.

Neuroreport. 1993 Jun;4(6):655-8.

PMID: 7688588 [PubMed - indexed for MEDLINE]

Recent Activity